JPS61192299A - Method of dyeing peroxidase - Google Patents

Method of dyeing peroxidase

Info

Publication number
JPS61192299A
JPS61192299A JP60031544A JP3154485A JPS61192299A JP S61192299 A JPS61192299 A JP S61192299A JP 60031544 A JP60031544 A JP 60031544A JP 3154485 A JP3154485 A JP 3154485A JP S61192299 A JPS61192299 A JP S61192299A
Authority
JP
Japan
Prior art keywords
staining
solution
peroxidase
buffer
pyrophosphoric acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP60031544A
Other languages
Japanese (ja)
Inventor
Shozo Nomoto
野本 昭三
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHINOTESUTO KENKYUSHO KK
Shino Test Corp
Original Assignee
SHINOTESUTO KENKYUSHO KK
Shino Test Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHINOTESUTO KENKYUSHO KK, Shino Test Corp filed Critical SHINOTESUTO KENKYUSHO KK
Priority to JP60031544A priority Critical patent/JPS61192299A/en
Publication of JPS61192299A publication Critical patent/JPS61192299A/en
Pending legal-status Critical Current

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

PURPOSE:To perform simply he titled dyeing useful for diagnosing acute leukemia, etc., capable of carrying out surely dyeing independently of impure substances in a buffer solution, not fading, having good dyeability, by using pyrophosphoric acid or its salt. CONSTITUTION:In a method using 3,3',5,5'-tetramethylbenzidine of its salt as a substrate, peroxidase is dyed by using pyrophosphoric acid or its salt.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は、ペルオキシダーゼの染色方法に関するもので
、主として医学的診断において利用しようとするもので
ある。
DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] The present invention relates to a peroxidase staining method, and is mainly intended for use in medical diagnosis.

〔従来の技術〕[Conventional technology]

ペルオキシダーゼの染色は、血液疾患の日常検査として
主として急性白血病の診断に際し骨髄性とリンパ性白血
病の鑑別に用いられン、又、ミニロバ−オキシダーゼ欠
乏症の診断にも用いられる。ペルオキシダーゼは過酸化
水素の存在下で種々の物質を酸化する反応を触媒する酵
素であるが、細胞化学反応によるペルオキシダーゼの検
出は基質である水素供給体が酵素により酸化され、A 
H2+H2022哨”2 A + 2 I−T20の反
応が起こり、酸化物が発色することに基づいている。
Peroxidase staining is used as a routine test for blood diseases, primarily to differentiate between myeloid and lymphocytic leukemia when diagnosing acute leukemia, and is also used for diagnosing miniloba-oxidase deficiency. Peroxidase is an enzyme that catalyzes reactions that oxidize various substances in the presence of hydrogen peroxide. Detection of peroxidase through cell chemical reactions indicates that the substrate hydrogen donor is oxidized by the enzyme.
It is based on the reaction of H2 + H2022 2 A + 2 I-T20 occurring and the oxide developing color.

従来、ペルオキシダーゼ染色方法には、ベンチジンを基
質とする方法が多用されてきたが、ベンチジンは発癌性
物質としてその使用に問題があるので、これに代わる他
の物質を基質として使用する方法が幾つか報告されてい
る。しかし、例えばフルオレイン誘導体を用いる方法で
は弱陽性顆粒の判定が困難であり、ナフトール誘導体を
用いる方法では封入しないと退色し、カルバゾール誘導
体を用いる方法では染色操作が複雑であるとされている
〔検査と技術、岳。
Traditionally, peroxidase staining methods have often used methods that use benzidine as a substrate, but since benzidine is a carcinogenic substance and its use is problematic, there are several alternative methods that use other substances as a substrate. It has been reported. However, for example, it is difficult to determine weakly positive granules with the method using fluorine derivatives, the color fades if not encapsulated with the method using naphthol derivatives, and the staining procedure is complicated with the method using carbazole derivatives. and technology, Gaku.

327 (1978))。他方も3.3′,5,5′−
テトラメチルベンチジン(以下、TMBと記す)を基質
に用いた報告もある〔倍大・医短・紀要、7.29 (
1981))。しかし、この方法は高純度のリン酸緩衝
液で染色反応を行なうと染色されないことにしばしば遭
遇する。
327 (1978)). The other one is also 3.3', 5,5'-
There is also a report using tetramethylbenzidine (hereinafter referred to as TMB) as a substrate [Beidai Medical Journal Bulletin, 7.29 (
1981)). However, this method often encounters no staining when the staining reaction is performed with a highly purified phosphate buffer.

〔発明が解決しようとする問題点〕[Problem that the invention seeks to solve]

本発明は、特にTMBを用いたペルオキシダーゼ染色法
において、染色試薬に用いる緩衝液中の不純物質依存に
よること々く確実に染色が行なえ、かつ退色しない安定
で染色性の良い、操作の簡単な方法を提供することにあ
る。
In particular, the present invention is a peroxidase staining method using TMB, which is an easy-to-operate method that allows staining to be performed reliably and without fading due to the dependence on impurities in the buffer used as a staining reagent, and which is stable and has good staining properties. Our goal is to provide the following.

本発明者は、TMBに関する前記報告に基づいてTMB
を用いたリン酸系の緩衝液でペルオキシダーゼ染色を行
なった場合に反応が起こらないという治験に基づいて検
討した結果、ピロリン酸を含ま々いリン酸塩を緩衝液と
して使用すると染色されないことを確認した。一方、リ
ン酸塩中のピロリン酸の含有量は、J工Sにおいて規定
されておらず、ピロリン酸を含むリン酸塩を入手できる
かどうかは偶然の結果でしか゛あり得ない状態であり、
かつその確率も現状では極めて希である。従って、もし
、ピロリン酸又はその塩類を含ま々いリン酸塩を緩衝液
として使用した場合、染色反応が起こら々いととになる
。TMBに関する前記報告には、緩衝液の種類の選択に
ついての検討結果として、リン酸緩衝液を用いることに
よってのみ染色されたと記載されている。これは、結局
リン酸の塩類に不純物として希に含まれていることもあ
るピロリン酸の存在に気付かないまま、リン酸緩衝液を
選出し、利用していたということになる。
Based on the above report regarding TMB, the present inventor has discovered that TMB
Based on a clinical trial in which no reaction occurred when peroxidase staining was performed with a phosphate-based buffer using did. On the other hand, the content of pyrophosphoric acid in phosphates is not specified in J.E.S., and the availability of phosphates containing pyrophosphoric acid is a matter of chance.
And the probability of that occurring is extremely rare at present. Therefore, if a phosphate containing pyrophosphoric acid or its salts is used as a buffer, no staining reaction will occur. The above report regarding TMB states that staining was achieved only by using a phosphate buffer as a result of consideration regarding the selection of the type of buffer. This means that the phosphate buffer was selected and used without being aware of the presence of pyrophosphoric acid, which is sometimes contained as an impurity in phosphoric acid salts.

本発明は、上記の問題点に鑑み検討した結果TMBを用
いるとき、ピロリン酸又はその塩類を染色試薬に添加す
ることによってペルオキシダーゼ染色が確実に行なえる
ことを見出し、本発明を完成した。
The present invention has been completed based on the findings that when TMB is used, peroxidase staining can be performed reliably by adding pyrophosphoric acid or its salts to the staining reagent.

〔問題点を解決するだめの手段〕[Failure to solve the problem]

本発明は、基質としてTMB又はその塩を用いるペルオ
キシダーゼ染色方法において、ピロリン酸又はその塩を
使用することを特徴とするペルオキシダーゼ染色方法で
ある。
The present invention is a peroxidase staining method using TMB or a salt thereof as a substrate, which is characterized by using pyrophosphoric acid or a salt thereof.

ペルオキシダーゼの染色方法は、全血を常法通りスライ
ドガラスに塗抹した標本、即ち試料に、TMBを含有す
る染色液を滴下し、数秒間放置後、緩衝液を追加して染
色を行々う。この際、使用するピロリン酸は予め試料に
添加してもよいし、或いは用いる緩衝液中に添加混合し
てもよい。こうして、染色反応を終了した後、必要あれ
ば後染色を行ない、流水水洗して乾燥後、鏡検する。
In the peroxidase staining method, a staining solution containing TMB is dropped onto a sample prepared by smearing whole blood onto a slide glass in a conventional manner, and after allowing the sample to stand for several seconds, a buffer solution is added and staining is carried out. At this time, the pyrophosphoric acid used may be added to the sample in advance, or may be added and mixed into the buffer solution used. After completing the staining reaction in this manner, post-staining is performed if necessary, washed with running water, dried, and examined under a microscope.

染色反応は、H5〜6.5付近の酸性条件下で行なうが
、この条件を満足させるものであればどんな緩衝液を用
いてもよい。ピロリン酸は1胴o II 71以上を使
用すれば染色性が発現するが、鏡検の見やすさ及び標本
の仕上がりの美しさを考えれば、2.Ortanol/
II前後に至適濃度がある。
The staining reaction is carried out under acidic conditions around H5 to 6.5, but any buffer may be used as long as it satisfies these conditions. Pyrophosphoric acid exhibits staining properties if 1-body o II 71 or higher is used, but considering the ease of viewing under a microscope and the beauty of the finished specimen, 2. Ortanol/
There is an optimum concentration around II.

染色液は、基質としてのTMB、TMB溶解のだめのア
ルコール、過酸化水素及び金属イオンより成り、これを
用時調製する。
The staining solution consists of TMB as a substrate, alcohol for dissolving TMB, hydrogen peroxide, and metal ions, and is prepared immediately before use.

〔作用〕[Effect]

従来は発癌性のないTMBを用いてペルオキシダーゼ染
色を行なう場合、必ずリン酸又はその塩を緩衝液として
使用しなければ染色ができなかった。これは、リン酸の
塩類に不純物として含有されるピロリン酸を染色反応に
利用したものである。しかし、ピロリン酸を含有しない
リン酸塩を使用すると染色されない結果にガる。
Conventionally, when performing peroxidase staining using TMB, which is not carcinogenic, staining could only be carried out using phosphoric acid or its salt as a buffer. This uses pyrophosphoric acid, which is contained as an impurity in phosphoric acid salts, in the dyeing reaction. However, the use of phosphates that do not contain pyrophosphate will result in no staining.

従って、染色液の緩衝系にリン酸以外を用いることがで
きず制限をうけていた。
Therefore, it was not possible to use anything other than phosphoric acid in the buffer system of the staining solution, which was a limitation.

本発明によれば、ピロリン酸を用い゛ることにより染色
液の緩衝系にリン酸又はその塩る用いる必要がなく々す
、広く緩衝液を選択できる。
According to the present invention, by using pyrophosphoric acid, there is no need to use phosphoric acid or its salt in the buffer system of the staining solution, and a wide range of buffer solutions can be selected.

又、仮にリン酸系の緩衝液を用いてもピロリン酸又はそ
の塩を使用することにより、確実に染色が行なえること
になる。
Furthermore, even if a phosphate buffer is used, staining can be performed reliably by using pyrophosphoric acid or its salt.

〔実施例〕〔Example〕

以下、本発明方法を試験例及び実施例により具体的に説
明する0 試験例1 リン酸二すトリウムのロット差による染色性
の差 試薬 (1)染色液 0−2 %TMB s o %メタノール水溶液10m
1,3%過酸化水素水0.04rnl、 10 %硫酸
亜鉛水溶液o、7mlを用時混合して染色液とする。
The method of the present invention will be specifically explained below using Test Examples and Examples.0 Test Example 1 Differences in staining properties due to lot differences in distrium phosphate Reagent (1) Staining solution 0-2% TMB s o % methanol aqueous solution 10m
Before use, mix 0.04 rnl of 1.3% hydrogen peroxide solution and 7 ml of 10% zinc sulfate aqueous solution to prepare a staining solution.

(2)緩衝液 −I/I’5Mリン酸二水素カリウム溶液と1/15M
IJン酸−水素ナトリウム溶液を混合して、H6,4に
調製する。
(2) Buffer solution - I/I'5M potassium dihydrogen phosphate solution and 1/15M
Mix the IJ acid-sodium hydrogen solution to prepare H6.4.

染色方法 試料(血液塗抹標本)に染色液1 mlを滴下し、室温
にて30秒間静置する。次いで、緩衝液2 mlを追加
し、混和後、室温で5分間反応させる。後染色はサフラ
ニン0溶液を用いる。
Staining method: Drop 1 ml of staining solution onto the sample (blood smear) and let stand at room temperature for 30 seconds. Next, add 2 ml of buffer solution, mix, and allow to react at room temperature for 5 minutes. Safranin 0 solution is used for post-staining.

(3)結果 第1表 上記の表の通り、リン酸緩衝液に用いたリン酸二ナイリ
ウムのロットによって染色性に差を生じた。
(3) Results Table 1 As shown in the table above, there were differences in staining properties depending on the lot of dinylium phosphate used in the phosphate buffer.

試験例2 ピロリン酸の染色性への効果5wmall/
l水溶液のピロリン酸の1滴を、比較例1で染色されな
かったロットの緩衝液16m1に加えて、比較例1で用
いた試薬と染色方法で染色を行なう。この結果、ピロリ
ン酸を添加すれば染色が行なわれることが判明した。こ
の際、添加するピロリン酸の濃度依存による染色性の結
果は、第2表の通りである。
Test Example 2 Effect of pyrophosphoric acid on dyeability 5wmall/
One drop of pyrophosphoric acid in an aqueous solution is added to 16 ml of the buffer solution of the lot that was not stained in Comparative Example 1, and staining is carried out using the reagent and staining method used in Comparative Example 1. As a result, it was found that staining can be achieved by adding pyrophosphoric acid. At this time, the results of stainability depending on the concentration of pyrophosphoric acid added are shown in Table 2.

第2表 実施例1 試薬 (1)染色液 0.2係TMBso%メタノール水溶液10ml、3%
過酸化水素水0.04 ml 、  10%硫酸亜鉛水
溶液o、tml及び0.07mol/lリン酸緩衝液(
、H6゜4)2omlを用時混合して染色液とする。
Table 2 Example 1 Reagent (1) Staining solution 0.2 TMBso% methanol aqueous solution 10ml, 3%
Hydrogen peroxide solution 0.04 ml, 10% zinc sulfate aqueous solution o, tml and 0.07 mol/l phosphate buffer (
, H6゜4) 2 oml are mixed before use to make a staining solution.

(2)  ピロリン酸ナトリウム水溶液5rranol
l/l水溶液に調製する。
(2) Sodium pyrophosphate aqueous solution 5rranol
Prepare a l/l aqueous solution.

(3)後染色液 1%サフラニン0水溶液と1/15Mリン酸緩衝液(、
H6゜4)を1:3の割合に混合して調製する。
(3) Post-staining solution 1% safranin 0 aqueous solution and 1/15M phosphate buffer (,
Prepare by mixing H6°4) at a ratio of 1:3.

染色方法 試料(血液塗抹標本)にピ01Jン酸水溶液1mlを滴
下し、室温にて30秒間静置し1分後に染色液2 ml
を混合し、室温で5分間放置する。この後、後染色液2
 mlを用いて後染色を行ない、水洗・乾燥した後、鏡
検する。
Staining method: Drop 1 ml of PI-01J aqueous solution onto the sample (blood smear), let stand at room temperature for 30 seconds, and after 1 minute add 2 ml of staining solution.
Mix and leave at room temperature for 5 minutes. After this, post-staining solution 2
ml for post-staining, washing with water, drying, and microscopic examination.

実施例2 試薬 、実施例1における染色液にピロリン酸すトリウムを最
終濃度1〜10mmol/lとなるように添加して調製
したものを染色液とする。
Example 2 A staining solution is a reagent prepared by adding thorium pyrophosphate to the staining solution in Example 1 to a final concentration of 1 to 10 mmol/l.

後染色液は実例1と同様。The post-staining solution was the same as in Example 1.

染色方法 試料(血液塗抹標本)に染色液3 m、lを滴下し、室
温で5分間静置する。この後、後染色液2 mlを用い
て後染色を行々い、水洗・乾燥して、鏡検する。
Staining method: Drop 3 ml of staining solution onto the sample (blood smear) and let stand at room temperature for 5 minutes. After this, post-staining is performed using 2 ml of post-staining solution, washed with water, dried, and examined microscopically.

実施例3 試薬 (1)染色液 0.15%TMB80%メタノール水溶液10m、l、
3%過酸化水素水1ml、10%硫酸亜鉛水溶液0 、
02 mlを用時混合して染色液とする。
Example 3 Reagent (1) Staining solution 0.15% TMB 80% methanol aqueous solution 10 ml,
3% hydrogen peroxide solution 1ml, 10% zinc sulfate solution 0,
02 ml is mixed before use to make a staining solution.

(2)緩衝液 0゜1rrLOl/lピロリン酸ナトリウム0.5ml
と0.1mo 11/Itグツドバツフ 7(pHpH
6−4)11を用時混合して緩衝液とする。
(2) Buffer solution 0゜1rrLOl/l sodium pyrophosphate 0.5ml
and 0.1mo 11/It Gutsudovatufu 7 (pHpH
6-4) Mix 11 before use to prepare a buffer solution.

(3)後染色液 1チサフラニンO水溶液と1/15Mグツドバッフy 
 (pH6,4)を1:3の割合に混合して調製する。
(3) Post-staining solution 1 tisafranin O aqueous solution and 1/15M Guttudo buffer y
(pH 6,4) at a ratio of 1:3.

染色方法 試料(血液塗抹標本)上に、染色液を0゜5 m1滴下
し30秒間放置、緩衝液を1mA!追間放置後水洗・乾
燥して鏡検する。
Staining method: Drop 0°5 ml of staining solution onto the sample (blood smear), leave for 30 seconds, and add 1mA of buffer solution! After leaving it for a while, wash it with water, dry it, and examine it under a microscope.

実施例4 試薬 0.2%TMBの80チメタノール水溶液1oynl、
3t$過酸化水素水0.04m1. 10チ硫酸亜鉛水
溶液0.7m、f!及びs razoll/lビロリン
酸ナトリウムを含むo、xmog/zグツド緩衝液(p
H6,4) 20 rnlを用時混合して染色液とする
。後染色液は実施例3と同様。
Example 4 Reagent 1 oynl of 80 timethanol aqueous solution of 0.2% TMB,
3t$ hydrogen peroxide solution 0.04ml1. 10 Zinc sulfate aqueous solution 0.7 m, f! and srazoll/l sodium birophosphate in o,xmog/zgud buffer (p
H6,4) Mix 20 rnl before use to make a staining solution. The post-staining solution was the same as in Example 3.

染色方法 実施例2の染色方法と同様。Dyeing method Same as the dyeing method in Example 2.

実施例5 試薬 実施例2と同様。Example 5 reagent Same as Example 2.

染色方法 クリオスタノトで薄切された肝組織をスライドグラスに
貼り付け、ホルムアルデヒドで常法通り固定し、水洗す
る。これに、ペルオキシダーゼを標識した抗HBs抗原
抗体を含むPBS (食塩加リン酸緩衝液)2 mlを
のせ、湿潤筒中室温で2時間放置後、冷却したPBSで
1晩洗浄する。このスライドグラスに染色液3 mll
を滴下し、室温で5分間静置する。この後、後染色液2
rnlを用いて後染色を行ない、水洗・乾燥して鏡検す
る。
Staining method: Paste liver tissue sliced with cryostanoto onto a slide glass, fix with formaldehyde as usual, and wash with water. 2 ml of PBS (phosphate buffered saline) containing a peroxidase-labeled anti-HBs antigen antibody is placed on this, left in a humid cylinder at room temperature for 2 hours, and then washed overnight with chilled PBS. Add 3 ml of staining solution to this slide glass.
dropwise and let stand at room temperature for 5 minutes. After this, post-staining solution 2
Post-stain with rnl, wash with water, dry, and examine under a microscope.

実施例6 試薬 実施例2と同様。Example 6 reagent Same as Example 2.

パラフィン包埋による肝組織の薄切標本を常法に従って
脱パラフイン後、抗HB s抗原抗体を含むPBSで室
温24時間洗浄後、ペルオキシダーゼを標識した第二抗
体を2時間反応させて冷却しだPBsで1晩色浄する。
A paraffin-embedded thin section of liver tissue was deparaffinized using a conventional method, washed with PBS containing anti-HBs antigen antibody at room temperature for 24 hours, reacted with a second antibody labeled with peroxidase for 2 hours, and cooled. Cleanse overnight.

この標本如染色液3 mlを滴下し、室温で5分間静置
する。この後、後染色液2mlを用いて後染色を行ない
、水洗・乾燥して鏡検する。
Add 3 ml of this sample staining solution dropwise and let stand at room temperature for 5 minutes. Thereafter, post-staining is performed using 2 ml of post-staining solution, followed by washing with water, drying, and microscopic examination.

特許出願人 株式会社ジノテスト研究所手続補正書(方
式) 昭和60年6月ノア日
Patent applicant Gino Test Institute Co., Ltd. Procedural amendment (method) June 1985 Noah date

Claims (1)

【特許請求の範囲】[Claims] 基質として3,3′,5,5′−テトラメチルベンチジ
ン又はその塩を用いるペルオキシダーゼ染色方法におい
て、ピロリン酸又はその塩を使用することを特徴とする
ペルオキシダーゼ染色方法。
1. A peroxidase staining method using 3,3',5,5'-tetramethylbenzidine or a salt thereof as a substrate, the method comprising using pyrophosphoric acid or a salt thereof.
JP60031544A 1985-02-21 1985-02-21 Method of dyeing peroxidase Pending JPS61192299A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP60031544A JPS61192299A (en) 1985-02-21 1985-02-21 Method of dyeing peroxidase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60031544A JPS61192299A (en) 1985-02-21 1985-02-21 Method of dyeing peroxidase

Publications (1)

Publication Number Publication Date
JPS61192299A true JPS61192299A (en) 1986-08-26

Family

ID=12334130

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60031544A Pending JPS61192299A (en) 1985-02-21 1985-02-21 Method of dyeing peroxidase

Country Status (1)

Country Link
JP (1) JPS61192299A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0299864A (en) * 1988-10-07 1990-04-11 Kazuo Murakami Measurement of angiotensin ii
JPH0299863A (en) * 1988-10-07 1990-04-11 Kazuo Murakami Measurement of angiotensin i
JPH04231872A (en) * 1990-05-11 1992-08-20 Eastman Kodak Co Use or protein containing heme as stabilizing agent for enzyme-label immunity reagent

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5467691A (en) * 1977-11-09 1979-05-31 Daiichi Denshi Kogyo Method of connecting conduction portion and conductive pressure sensing adhesives
JPS5522773Y2 (en) * 1976-10-26 1980-05-30

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522773Y2 (en) * 1976-10-26 1980-05-30
JPS5467691A (en) * 1977-11-09 1979-05-31 Daiichi Denshi Kogyo Method of connecting conduction portion and conductive pressure sensing adhesives

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0299864A (en) * 1988-10-07 1990-04-11 Kazuo Murakami Measurement of angiotensin ii
JPH0299863A (en) * 1988-10-07 1990-04-11 Kazuo Murakami Measurement of angiotensin i
JPH04231872A (en) * 1990-05-11 1992-08-20 Eastman Kodak Co Use or protein containing heme as stabilizing agent for enzyme-label immunity reagent

Similar Documents

Publication Publication Date Title
JP2922003B2 (en) Improved compositions, tools and methods for assaying for peroxide active substances
JP3503890B2 (en) Improved immunohistochemical staining method and reagents therefor
Vanderlinde Measurement of total lactate dehydrogenase activity
US20070154976A1 (en) Method of determining substrate contained in hemoglobin-containing sample
US5156947A (en) Process for reduction of the matrix effect in a fructosamine determination assay
EP0207936A1 (en) Enzyme immunoassay with two-part solution of tetramethylbenzidine as chromogen
US4525452A (en) Enzyme immunoassay with step of immersing sample in deionized water
JPH0661277B2 (en) Stabilization of indicator for enzyme activity detection
US4940660A (en) Color developing method in clinical examinations
JPS5813398A (en) Agent and method for detecting hydrogen peroxide, substrate containing same, peroxidase and substance having peroxidase like action
JPH03182562A (en) Compound for quantitative measurement of reticular erythrocyte in whole blood, reagent composition and its use
CN109613280B (en) Serum iron determination kit and preparation method and application thereof
Ohnishi et al. Characterization of the catalyzed phosphate assay
US2999052A (en) Composition for colorimetric test for serum enzymes
Watson Enzymic determination of glucose and easily hydrolyzable glucose esters in blood
US4803158A (en) Composition used for the determination of beta-hydroxybutyric acid and a method for preparing the said composition
JPH0630633B2 (en) Method for detecting allergy, reagent and device suitable for the method, and method for measuring drug for allergy and anti-inflammatory agent
US5312759A (en) Method for measurement of fructosamines using 1,2-quinones
JPS61192299A (en) Method of dyeing peroxidase
US5106753A (en) Method for determining manganese level in blood using a porphyrin composition
CN112710854B (en) Anti-interference and stable serum total bilirubin (enzyme method) determination kit and preparation method and application thereof
Venkataraman et al. Method for the estimation of acetylisoniazid in urine
JP4577863B2 (en) Composition for measuring calcium ion and measuring method
KR100379646B1 (en) Reagent composition, test piece and measurement kit
JP2694004B2 (en) Method for measuring fructosamine in serum or plasma